Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

H Paul Klingenstein

Affiliations

  • Director at Clovis Oncology Inc. (CLVS), 2019-07-31
  • Director at Anacor Pharmaceuticals Inc. (ANAC), 2014-05-30
  • Director at Conatus Pharmaceuticals Inc (CNAT), 2014-02-25
  • Director at Enteromedics Inc (ETRM), 2013-05-10
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CNAT $11.00 2,470 Large Shareholder, Director 52,419 2013-07-30 Filing
CNAT $11.00 104,952 Large Shareholder, Director 2,226,944 2013-07-30 Filing
CLVS $13.00 7,813 Director 25,509 2011-11-21 Filing
CLVS $13.00 391,478 Director 1,278,156 2011-11-21 Filing
ANAC $5.00 300,000 Director 1,751,936 2010-11-30 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CNAT $11.00 14 Large Shareholder, Director 49,698 2013-07-30 Filing
CNAT $11.00 552 Large Shareholder, Director 2,111,378 2013-07-30 Filing